Get the Stockscreener App
5.42
2.34%
-0.13
After Hours:
5.40
-0.02
-0.37%
Entrada Therapeutics Inc stock is traded at $5.42, with a volume of 489.35K.
It is down -2.34% in the last 24 hours and down -3.56% over the past month.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
See More
Previous Close:
$5.55
Open:
$5.6
24h Volume:
489.35K
Relative Volume:
1.98
Market Cap:
$206.16M
Revenue:
$239.40M
Net Income/Loss:
$104.44M
P/E Ratio:
1.8311
EPS:
2.96
Net Cash Flow:
$-18.50M
1W Performance:
+2.65%
1M Performance:
-3.56%
6M Performance:
-49.58%
1Y Performance:
-63.87%
1-Day Range:
$5.40
$5.77
1-Week Range:
$5.02
$5.77
52-Week Range:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Name
Entrada Therapeutics Inc
Sector
Industry
Phone
857-305-1825
Address
ONE DESIGN CENTER PLACE, BOSTON
Compare TRDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
5.42 | 211.11M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | ROTH MKM | Buy |
| Jan-05-24 | Initiated | Oppenheimer | Outperform |
| Apr-03-23 | Initiated | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Stock (TRDA) Latest News
Wall Street Recap: Will Entrada Therapeutics Inc stock recover after earningsQuarterly Earnings Report & Proven Capital Preservation Methods - khodrobank.com
Sentiment Recap: What are Entrada Therapeutics Incs recent SEC filings showingOptions Play & Precise Entry and Exit Recommendations - khodrobank.com
Will Entrada Therapeutics Inc. continue its uptrendWeekly Investment Summary & Low Volatility Stock Recommendations - newser.com
Aug Summary: Will Entrada Therapeutics Inc benefit from rising consumer demandIndex Update & Verified Swing Trading Watchlist - khodrobank.com
will entrada therapeutics inc. price bounce be sustainablePortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Aug Retail: Will Entrada Therapeutics Inc outperform the market in YEAREarnings Risk Summary & Detailed Earnings Play Strategies - khodrobank.com
Chart based analysis of Entrada Therapeutics Inc. trendsMarket Trend Review & AI Driven Stock Reports - newser.com
How to manage a losing position in Entrada Therapeutics Inc.Weekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com
Evaluating Entrada Therapeutics Inc. with trendline analysisTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Fed Meeting: Is Entrada Therapeutics Inc. subject to activist investor interestWatch List & Advanced Swing Trade Entry Alerts - khodrobank.com
Real time scanner hits for Entrada Therapeutics Inc. explained2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Is this a good reentry point in Entrada Therapeutics Inc.2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
Statistical indicators supporting Entrada Therapeutics Inc.’s strengthQuarterly Profit Report & Long-Term Investment Growth Plans - newser.com
Will Entrada Therapeutics Inc. price bounce be sustainableMarket Activity Report & Real-Time Volume Spike Alerts - newser.com
Entrada Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Short Interest & AI Based Buy and Sell Signals - newser.com
Smart tools for monitoring Entrada Therapeutics Inc.’s price actionMarket Performance Report & Reliable Breakout Forecasts - newser.com
How institutional ownership impacts Entrada Therapeutics Inc. stock2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
How to forecast Entrada Therapeutics Inc. trends using time seriesWeekly Trend Recap & Real-Time Buy Signal Alerts - newser.com
Aug Sentiment: How is FRBA managing supply chain issuesStock Surge & Fast Entry Momentum Trade Alerts - خودرو بانک
Smart Money: Is Entrada Therapeutics Inc. currently under institutional pressureTrade Exit Summary & Accurate Technical Buy Alerts - خودرو بانک
will entrada therapeutics inc. continue its uptrendMarket Risk Report & Short-Term High Return Ideas - newser.com
Patterns Watch: Is Entrada Therapeutics Inc benefiting from innovation trendsBear Alert & Accurate Buy Signal Alerts - khodrobank.com
Sell Signal: Should I add Exelixis Inc stock to my portfolioEarnings Growth Summary & Real-Time Volume Triggers - خودرو بانک
Aug PostEarnings: Is Entrada Therapeutics Inc. a top pick in the sector2025 Trading Recap & Weekly Stock Breakout Alerts - khodrobank.com
Should you hold or exit Entrada Therapeutics Inc. nowJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
Market Trends: What is Entrada Therapeutics Incs 5 year growth outlookJuly 2025 Technicals & Real-Time Buy Zone Alerts - khodrobank.com
Energy Moves: What chart patterns are forming on Able View Global Inc. Equity WarrantWeekly Gains Summary & Weekly Top Performers Watchlists - خودرو بانک
Risk Hedge: What is Entrada Therapeutics Incs market positionJuly 2025 Snapshot & AI Driven Price Predictions - خودرو بانک
Breakouts Watch: What are Entrada Therapeutics Incs recent SEC filings showingQuarterly Growth Report & Fast Entry High Yield Stock Tips - khodrobank.com
Entry Recap: Can Entrada Therapeutics Inc ride the EV wave2025 Geopolitical Influence & High Return Trade Opportunity Guides - خودرو بانک
Analyst Upgrade: Can Entrada Therapeutics Inc ride the EV waveTrade Risk Assessment & Growth Focused Stock Pick Reports - خودرو بانک
Guidance Update: How does Entrada Therapeutics Inc compare to its peersPrice Action & AI Forecasted Entry and Exit Points - khodrobank.com
Earnings Report: Can Entrada Therapeutics Inc. disrupt its industry2025 Risk Factors & Long Hold Capital Preservation Tips - khodrobank.com
Growth Report: Will Entrada Therapeutics Inc stock recover after earningsJuly 2025 Final Week & Weekly Breakout Watchlists - khodrobank.com
Forecast Cut: What are the risks of holding Entrada Therapeutics IncWeekly Gains Report & Short-Term Trading Opportunity Alerts - khodrobank.com
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Receives $25.67 Consensus Target Price from Analysts - MarketBeat
Growth Value: Is Entrada Therapeutics Inc benefiting from innovation trendsQuarterly Market Review & Real-Time Chart Pattern Alerts - خودرو بانک
Using Ichimoku Cloud for Entrada Therapeutics Inc. technicals2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - newser.com
statistical indicators supporting entrada therapeutics inc.’s strengthWeekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
Entrada Therapeutics Shares Face Mounting Pressure as Technicals and Fundamentals Diverge - AD HOC NEWS
Entrada Therapeutics Inc Stock (TRDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):